WallStreetZenWallStreetZen

NASDAQ: CBIO
Crescent Biopharma Inc Stock Ownership - Who owns Crescent Biopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Crescent Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Invus Public Equities LP10% Owner2024-08-08260,873$0.19
$50.09kSell
Invus Public Equities LP10% Owner2024-08-0761,488$0.18
$11.19kSell
Invus Public Equities LP10% Owner2024-08-0655,732$0.18
$10.20kSell
Invus Public Equities LP10% Owner2024-08-05164,523$0.19
$30.93kSell
Invus Public Equities LP10% Owner2024-08-02286,200$0.20
$57.24kSell
Invus Public Equities LP10% Owner2024-08-0163,564$0.22
$13.73kSell
Invus Public Equities LP10% Owner2024-07-30756,835$0.22
$167.26kSell
Invus Public Equities LP10% Owner2024-07-29363,949$0.24
$85.53kSell
Invus Public Equities LP10% Owner2024-07-26258,335$0.24
$62.52kSell

1 of 1

CBIO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CBIO insiders and whales buy or sell their stock.

CBIO Shareholders

What type of owners hold Crescent Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Scott D. Sandell2,178.23%14,056,571$207.90MInsider
Peter J. Barris2,042.77%13,182,418$194.97MInsider
M. James Barrett2,042.77%13,182,418$194.97MInsider
Bvf Inc1,478.99%9,544,262$141.16MInstitution
Siren LLC1,330.98%8,589,064$127.03MInsider
Invus Public Equities LP978.98%6,317,565$93.44MInsider
Logos Global Management LP836.79%5,400,000$79.87MInstitution
Adage Capital Partners GP LLC788.95%5,091,231$75.30MInstitution
New Enterprise Associates 10 L P774.14%4,995,664$73.89MInsider
New Enterprise Associates 13 LP634.32%4,093,377$60.54MInsider

1 of 3

CBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CBIO30.02%69.98%Net Selling
JBIO64.29%35.71%Net BuyingNet Buying
TRAW6.32%93.68%Net Buying
TSBX42.44%57.56%
XFOR93.26%6.74%Net SellingNet Buying
View Top Biotech Stocks

Crescent Biopharma Stock Ownership FAQ

Who owns Crescent Biopharma?

Crescent Biopharma (NASDAQ: CBIO) is owned by 4,763.94% institutional shareholders, 11,105.64% Crescent Biopharma insiders, and 0.00% retail investors. Scott D. Sandell is the largest individual Crescent Biopharma shareholder, owning 14.06M shares representing 2,178.23% of the company. Scott D. Sandell's Crescent Biopharma shares are currently valued at $189.76M.

If you're new to stock investing, here's how to buy Crescent Biopharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.